

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 5.00162529 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.96818553 |
| 3 | protein neddylation (GO:0045116) | 4.60039199 |
| 4 | adenosine receptor signaling pathway (GO:0001973) | 4.59243124 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.23769338 |
| 6 | blood coagulation, intrinsic pathway (GO:0007597) | 4.00959289 |
| 7 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.97701509 |
| 8 | negative regulation of norepinephrine secretion (GO:0010700) | 3.96131239 |
| 9 | regulation of platelet aggregation (GO:0090330) | 3.93346075 |
| 10 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.74904368 |
| 11 | low-density lipoprotein particle remodeling (GO:0034374) | 3.73854072 |
| 12 | platelet aggregation (GO:0070527) | 3.59908963 |
| 13 | regulation of platelet activation (GO:0010543) | 3.50564480 |
| 14 | lipoxygenase pathway (GO:0019372) | 3.47845625 |
| 15 | vesicle targeting (GO:0006903) | 3.45968356 |
| 16 | negative regulation of adherens junction organization (GO:1903392) | 3.38839749 |
| 17 | negative regulation of focal adhesion assembly (GO:0051895) | 3.38839749 |
| 18 | negative regulation of cell junction assembly (GO:1901889) | 3.38839749 |
| 19 | regulation of interleukin-13 production (GO:0032656) | 3.27843416 |
| 20 | negative regulation of platelet activation (GO:0010544) | 3.18674740 |
| 21 | positive regulation of receptor recycling (GO:0001921) | 3.14301760 |
| 22 | negative regulation of protein localization to cell surface (GO:2000009) | 3.14204229 |
| 23 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.11427109 |
| 24 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.09566166 |
| 25 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.07973842 |
| 26 | platelet degranulation (GO:0002576) | 3.05998855 |
| 27 | regulation of lipoprotein metabolic process (GO:0050746) | 3.03990160 |
| 28 | negative regulation of heart rate (GO:0010459) | 2.99951463 |
| 29 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99655943 |
| 30 | axonemal dynein complex assembly (GO:0070286) | 2.96175519 |
| 31 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.92430421 |
| 32 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.91110759 |
| 33 | activation of protein kinase A activity (GO:0034199) | 2.90959058 |
| 34 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.88461946 |
| 35 | neutrophil activation (GO:0042119) | 2.88287030 |
| 36 | platelet activation (GO:0030168) | 2.87062950 |
| 37 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.85619849 |
| 38 | regulation of early endosome to late endosome transport (GO:2000641) | 2.83396475 |
| 39 | regulation of integrin activation (GO:0033623) | 2.81849746 |
| 40 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.77428848 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 2.76605248 |
| 42 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.75055448 |
| 43 | regulation of female receptivity (GO:0045924) | 2.72850551 |
| 44 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.72353144 |
| 45 | actin filament polymerization (GO:0030041) | 2.69975345 |
| 46 | L-phenylalanine metabolic process (GO:0006558) | 2.69199592 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.69199592 |
| 48 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.68665377 |
| 49 | negative regulation of catecholamine secretion (GO:0033604) | 2.67143940 |
| 50 | myelin maintenance (GO:0043217) | 2.65883794 |
| 51 | high-density lipoprotein particle remodeling (GO:0034375) | 2.65594923 |
| 52 | beta-amyloid metabolic process (GO:0050435) | 2.63779860 |
| 53 | homotypic cell-cell adhesion (GO:0034109) | 2.63227359 |
| 54 | negative regulation of heart contraction (GO:0045822) | 2.61506569 |
| 55 | autophagic vacuole fusion (GO:0000046) | 2.61198726 |
| 56 | regulation of receptor recycling (GO:0001919) | 2.60392260 |
| 57 | reverse cholesterol transport (GO:0043691) | 2.54656885 |
| 58 | water transport (GO:0006833) | 2.54049552 |
| 59 | regulation of norepinephrine secretion (GO:0014061) | 2.53716974 |
| 60 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.53134822 |
| 61 | granulocyte activation (GO:0036230) | 2.52939791 |
| 62 | cyclooxygenase pathway (GO:0019371) | 2.50945572 |
| 63 | signal complex assembly (GO:0007172) | 2.50885568 |
| 64 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.48989315 |
| 65 | cellular response to prostaglandin stimulus (GO:0071379) | 2.47619747 |
| 66 | protein insertion into membrane (GO:0051205) | 2.46581286 |
| 67 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.45670687 |
| 68 | purinergic receptor signaling pathway (GO:0035587) | 2.44442239 |
| 69 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.44348873 |
| 70 | cerebellar granule cell differentiation (GO:0021707) | 2.43580052 |
| 71 | platelet formation (GO:0030220) | 2.43336248 |
| 72 | L-phenylalanine catabolic process (GO:0006559) | 2.40182253 |
| 73 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.40182253 |
| 74 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.39576201 |
| 75 | megakaryocyte development (GO:0035855) | 2.39549599 |
| 76 | peptide catabolic process (GO:0043171) | 2.39528896 |
| 77 | regulation of sensory perception (GO:0051931) | 2.39138991 |
| 78 | regulation of sensory perception of pain (GO:0051930) | 2.39138991 |
| 79 | motile cilium assembly (GO:0044458) | 2.38459010 |
| 80 | angiogenesis involved in wound healing (GO:0060055) | 2.37304804 |
| 81 | positive regulation of blood coagulation (GO:0030194) | 2.36145351 |
| 82 | positive regulation of hemostasis (GO:1900048) | 2.36145351 |
| 83 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.35680187 |
| 84 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.35588561 |
| 85 | response to magnesium ion (GO:0032026) | 2.34117669 |
| 86 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.33873677 |
| 87 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.33783200 |
| 88 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.32940222 |
| 89 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.32845794 |
| 90 | regulation of cholesterol efflux (GO:0010874) | 2.32292515 |
| 91 | female mating behavior (GO:0060180) | 2.30240377 |
| 92 | negative regulation of appetite (GO:0032099) | 2.26436429 |
| 93 | negative regulation of response to food (GO:0032096) | 2.26436429 |
| 94 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.24857504 |
| 95 | epithelial cell-cell adhesion (GO:0090136) | 2.24849296 |
| 96 | regulation of cholesterol metabolic process (GO:0090181) | 2.23522432 |
| 97 | regulation of protein localization to cell surface (GO:2000008) | 2.22861137 |
| 98 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.22566315 |
| 99 | fluid transport (GO:0042044) | 2.22215170 |
| 100 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.21110626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.16740904 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.94093186 |
| 3 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.90575368 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.89527963 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.38310898 |
| 6 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.38259584 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31377064 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.28303019 |
| 9 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.26527815 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.23947149 |
| 11 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.22240825 |
| 12 | GATA1_19941826_ChIP-Seq_K562_Human | 2.21556454 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19647611 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00947712 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.97556211 |
| 16 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.93858394 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76528751 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73510004 |
| 19 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.73459209 |
| 20 | GATA2_19941826_ChIP-Seq_K562_Human | 1.72857423 |
| 21 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.70694665 |
| 22 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.70457249 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70196842 |
| 24 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66731268 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58162680 |
| 26 | P68_20966046_ChIP-Seq_HELA_Human | 1.57479032 |
| 27 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.56387279 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54391248 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53100964 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52750368 |
| 31 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52494544 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44624288 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.44181394 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43661841 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43177913 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42813995 |
| 37 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.42462488 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42144351 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41556754 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.39771978 |
| 41 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37741142 |
| 42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37136455 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36048117 |
| 44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.34586390 |
| 45 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33392462 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32963624 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32276303 |
| 48 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31185712 |
| 49 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29785917 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29476120 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27543078 |
| 52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.25819722 |
| 53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25356914 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25215834 |
| 55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24424576 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23833745 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23498881 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22590128 |
| 59 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22500131 |
| 60 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21359969 |
| 61 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18025441 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17547549 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17459663 |
| 64 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17409817 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16379330 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16329533 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13399270 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13191759 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12268671 |
| 70 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.12260941 |
| 71 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.11353045 |
| 72 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06833351 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06750112 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06550121 |
| 75 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.06214888 |
| 76 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.03596116 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01499327 |
| 78 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00465049 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99838144 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99440157 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98345031 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97424190 |
| 83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96695441 |
| 84 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95767926 |
| 85 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95334352 |
| 86 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.94337639 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94198523 |
| 88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93773334 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92937191 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92401429 |
| 91 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.92299257 |
| 92 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.92261910 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92123480 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91102986 |
| 95 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91025643 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90036190 |
| 97 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89303973 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89131559 |
| 99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88936761 |
| 100 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.88217279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 6.63425257 |
| 2 | MP0008004_abnormal_stomach_pH | 3.96482717 |
| 3 | MP0005083_abnormal_biliary_tract | 3.43694600 |
| 4 | MP0003879_abnormal_hair_cell | 2.99174702 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 2.75262012 |
| 6 | MP0004510_myositis | 2.65365923 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.49489983 |
| 8 | MP0005409_darkened_coat_color | 2.47845401 |
| 9 | MP0000465_gastrointestinal_hemorrhage | 2.25672386 |
| 10 | MP0002736_abnormal_nociception_after | 2.11292605 |
| 11 | MP0003303_peritoneal_inflammation | 2.01113830 |
| 12 | MP0003638_abnormal_response/metabolism_ | 1.94509523 |
| 13 | MP0005365_abnormal_bile_salt | 1.92173845 |
| 14 | MP0010329_abnormal_lipoprotein_level | 1.89664606 |
| 15 | MP0003724_increased_susceptibility_to | 1.87405871 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 1.87088327 |
| 17 | MP0001765_abnormal_ion_homeostasis | 1.85452695 |
| 18 | MP0001968_abnormal_touch/_nociception | 1.83567504 |
| 19 | MP0010155_abnormal_intestine_physiology | 1.82724144 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.73114198 |
| 21 | MP0001664_abnormal_digestion | 1.72624839 |
| 22 | MP0002132_abnormal_respiratory_system | 1.70572420 |
| 23 | MP0003866_abnormal_defecation | 1.69166633 |
| 24 | MP0000678_abnormal_parathyroid_gland | 1.67933794 |
| 25 | MP0008872_abnormal_physiological_respon | 1.65958352 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.59274020 |
| 27 | MP0000343_altered_response_to | 1.52546362 |
| 28 | MP0000230_abnormal_systemic_arterial | 1.50451184 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.50006305 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.48479303 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.46645476 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.45471546 |
| 33 | MP0001663_abnormal_digestive_system | 1.37448024 |
| 34 | MP0008874_decreased_physiological_sensi | 1.36069181 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 1.34221317 |
| 36 | MP0002796_impaired_skin_barrier | 1.33459801 |
| 37 | MP0001849_ear_inflammation | 1.31760771 |
| 38 | MP0008260_abnormal_autophagy | 1.31390693 |
| 39 | MP0005360_urolithiasis | 1.30728311 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.30445170 |
| 41 | MP0005501_abnormal_skin_physiology | 1.29628459 |
| 42 | MP0009840_abnormal_foam_cell | 1.28342582 |
| 43 | MP0004947_skin_inflammation | 1.23529167 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.23020832 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.22185144 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.21164047 |
| 47 | MP0005666_abnormal_adipose_tissue | 1.17570133 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.17502368 |
| 49 | MP0004130_abnormal_muscle_cell | 1.17078213 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.15211881 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.14328907 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.10972726 |
| 53 | MP0005381_digestive/alimentary_phenotyp | 1.09426286 |
| 54 | MP0000249_abnormal_blood_vessel | 1.09228589 |
| 55 | MP0008569_lethality_at_weaning | 1.08925551 |
| 56 | MP0004381_abnormal_hair_follicle | 1.08437901 |
| 57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04695097 |
| 58 | MP0004147_increased_porphyrin_level | 1.03950234 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.03570057 |
| 60 | MP0004270_analgesia | 1.02585978 |
| 61 | MP0001970_abnormal_pain_threshold | 1.02562552 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.01825637 |
| 63 | MP0000383_abnormal_hair_follicle | 1.01023504 |
| 64 | MP0005670_abnormal_white_adipose | 0.99772773 |
| 65 | MP0004043_abnormal_pH_regulation | 0.99334563 |
| 66 | MP0001756_abnormal_urination | 0.98021765 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 0.96365352 |
| 68 | MP0009642_abnormal_blood_homeostasis | 0.95629920 |
| 69 | MP0004036_abnormal_muscle_relaxation | 0.92857138 |
| 70 | MP0003880_abnormal_central_pattern | 0.91904322 |
| 71 | MP0002653_abnormal_ependyma_morphology | 0.91676910 |
| 72 | MP0006138_congestive_heart_failure | 0.91417602 |
| 73 | MP0008775_abnormal_heart_ventricle | 0.89212574 |
| 74 | MP0005535_abnormal_body_temperature | 0.87729282 |
| 75 | MP0005451_abnormal_body_composition | 0.86924158 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.86575011 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 0.86118292 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 0.84851368 |
| 79 | MP0005448_abnormal_energy_balance | 0.84100968 |
| 80 | MP0002064_seizures | 0.83762849 |
| 81 | MP0003075_altered_response_to | 0.83359553 |
| 82 | MP0000858_altered_metastatic_potential | 0.81671755 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.81317057 |
| 84 | MP0002822_catalepsy | 0.81108758 |
| 85 | MP0005165_increased_susceptibility_to | 0.79802449 |
| 86 | MP0010678_abnormal_skin_adnexa | 0.79800432 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.79669967 |
| 88 | MP0004484_altered_response_of | 0.79298899 |
| 89 | MP0005423_abnormal_somatic_nervous | 0.78417673 |
| 90 | MP0002735_abnormal_chemical_nociception | 0.78002478 |
| 91 | MP0001851_eye_inflammation | 0.77923131 |
| 92 | MP0003635_abnormal_synaptic_transmissio | 0.77898205 |
| 93 | MP0005410_abnormal_fertilization | 0.75040919 |
| 94 | MP0001533_abnormal_skeleton_physiology | 0.71674619 |
| 95 | MP0005375_adipose_tissue_phenotype | 0.71475696 |
| 96 | MP0002971_abnormal_brown_adipose | 0.70376373 |
| 97 | MP0000490_abnormal_crypts_of | 0.70223030 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.70202406 |
| 99 | MP0003436_decreased_susceptibility_to | 0.69868319 |
| 100 | MP0000579_abnormal_nail_morphology | 0.69331475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 8.05207246 |
| 2 | Menorrhagia (HP:0000132) | 7.77242396 |
| 3 | Increased mean platelet volume (HP:0011877) | 7.31159177 |
| 4 | Purpura (HP:0000979) | 7.28153866 |
| 5 | Petechiae (HP:0000967) | 7.02810977 |
| 6 | Abnormal platelet volume (HP:0011876) | 6.89241521 |
| 7 | Epistaxis (HP:0000421) | 5.30646317 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.61375584 |
| 9 | Gingival bleeding (HP:0000225) | 4.54035013 |
| 10 | Impaired platelet aggregation (HP:0003540) | 4.07180474 |
| 11 | Abnormal platelet function (HP:0011869) | 4.07180474 |
| 12 | Abnormal ciliary motility (HP:0012262) | 3.77099283 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 3.62596280 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.62596280 |
| 15 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.57719646 |
| 16 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.57719646 |
| 17 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.51869115 |
| 18 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.51452603 |
| 19 | Acanthocytosis (HP:0001927) | 3.44077495 |
| 20 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.42150957 |
| 21 | Poikilocytosis (HP:0004447) | 3.11838547 |
| 22 | Ventricular fibrillation (HP:0001663) | 3.07235492 |
| 23 | Rhinitis (HP:0012384) | 3.04406054 |
| 24 | Nasal polyposis (HP:0100582) | 2.96878787 |
| 25 | Xanthomatosis (HP:0000991) | 2.84887474 |
| 26 | Abnormal pupillary function (HP:0007686) | 2.72906556 |
| 27 | Male infertility (HP:0003251) | 2.69090996 |
| 28 | Spontaneous hematomas (HP:0007420) | 2.68693074 |
| 29 | Dyschromatopsia (HP:0007641) | 2.59693384 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 2.57856243 |
| 31 | J-shaped sella turcica (HP:0002680) | 2.57561710 |
| 32 | Hemorrhage of the eye (HP:0011885) | 2.57195058 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 2.49447295 |
| 34 | Hyperactive renin-angiotensin system (HP:0000841) | 2.48250644 |
| 35 | Bruising susceptibility (HP:0000978) | 2.43334381 |
| 36 | Ankle clonus (HP:0011448) | 2.41956006 |
| 37 | Abnormality of lateral ventricle (HP:0030047) | 2.41042750 |
| 38 | Hyperparathyroidism (HP:0000843) | 2.40838744 |
| 39 | Hyperthyroidism (HP:0000836) | 2.36342817 |
| 40 | Thin bony cortex (HP:0002753) | 2.29847376 |
| 41 | Joint hemorrhage (HP:0005261) | 2.21400394 |
| 42 | Testicular neoplasm (HP:0010788) | 2.15464693 |
| 43 | Bronchiectasis (HP:0002110) | 2.13279039 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 2.12896364 |
| 45 | Chronic bronchitis (HP:0004469) | 2.12518148 |
| 46 | Infertility (HP:0000789) | 2.11175919 |
| 47 | Hypophosphatemia (HP:0002148) | 2.09964320 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.06579219 |
| 49 | Muscle fiber splitting (HP:0003555) | 2.03614994 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.02691191 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.02033955 |
| 52 | Paralysis (HP:0003470) | 2.00308090 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 1.98816339 |
| 54 | Growth hormone excess (HP:0000845) | 1.98410309 |
| 55 | Bundle branch block (HP:0011710) | 1.95315064 |
| 56 | Hypercortisolism (HP:0001578) | 1.95289964 |
| 57 | Abnormality of macrophages (HP:0004311) | 1.90969440 |
| 58 | Abnormality of iron homeostasis (HP:0011031) | 1.89865925 |
| 59 | Obstructive sleep apnea (HP:0002870) | 1.87995929 |
| 60 | Increased serum ferritin (HP:0003281) | 1.87829225 |
| 61 | Conjunctival telangiectasia (HP:0000524) | 1.86181612 |
| 62 | Chronic otitis media (HP:0000389) | 1.83525674 |
| 63 | Increased density of long bones (HP:0006392) | 1.82726386 |
| 64 | Insidious onset (HP:0003587) | 1.80917143 |
| 65 | Termporal pattern (HP:0011008) | 1.80917143 |
| 66 | Abdominal distention (HP:0003270) | 1.80040912 |
| 67 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.79453228 |
| 68 | Myokymia (HP:0002411) | 1.78463169 |
| 69 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.77961303 |
| 70 | Cholecystitis (HP:0001082) | 1.76725919 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 1.76725919 |
| 72 | Back pain (HP:0003418) | 1.76112582 |
| 73 | Decreased central vision (HP:0007663) | 1.75717363 |
| 74 | Increased cerebral lipofuscin (HP:0011813) | 1.74310146 |
| 75 | Easy fatigability (HP:0003388) | 1.73026927 |
| 76 | Joint swelling (HP:0001386) | 1.72853611 |
| 77 | Visual hallucinations (HP:0002367) | 1.72788399 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 1.72708447 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71821481 |
| 80 | Tongue fasciculations (HP:0001308) | 1.71124972 |
| 81 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.71040783 |
| 82 | Atelectasis (HP:0100750) | 1.68281090 |
| 83 | Diplopia (HP:0000651) | 1.67741861 |
| 84 | Abnormality of binocular vision (HP:0011514) | 1.67741861 |
| 85 | Mitral stenosis (HP:0001718) | 1.67481768 |
| 86 | Adrenal overactivity (HP:0002717) | 1.66703175 |
| 87 | Generalized aminoaciduria (HP:0002909) | 1.64256607 |
| 88 | Nausea (HP:0002018) | 1.62927826 |
| 89 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.61596940 |
| 90 | Abnormality of renin-angiotensin system (HP:0000847) | 1.61036955 |
| 91 | Flat acetabular roof (HP:0003180) | 1.60888611 |
| 92 | Polyphagia (HP:0002591) | 1.60793966 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.60089007 |
| 94 | Muscle fibrillation (HP:0010546) | 1.59438437 |
| 95 | Decreased circulating renin level (HP:0003351) | 1.59255580 |
| 96 | Reticulocytosis (HP:0001923) | 1.58852324 |
| 97 | Metabolic alkalosis (HP:0200114) | 1.58120091 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 1.57461482 |
| 99 | Upper limb muscle weakness (HP:0003484) | 1.57048862 |
| 100 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.55322447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.56853421 |
| 2 | TRIB3 | 3.45946439 |
| 3 | BMX | 3.05142456 |
| 4 | MAPKAPK3 | 3.02675966 |
| 5 | MST4 | 2.88790134 |
| 6 | EPHA2 | 2.45945564 |
| 7 | SIK1 | 2.38428804 |
| 8 | MYLK | 2.28567107 |
| 9 | GRK6 | 2.07726729 |
| 10 | PKN2 | 2.07258298 |
| 11 | EIF2AK1 | 1.90802652 |
| 12 | ILK | 1.65713626 |
| 13 | MAPK15 | 1.64125959 |
| 14 | PTK2B | 1.54745059 |
| 15 | GRK5 | 1.52919528 |
| 16 | LMTK2 | 1.48264015 |
| 17 | TESK1 | 1.44657958 |
| 18 | PDPK1 | 1.43817036 |
| 19 | BTK | 1.40849315 |
| 20 | MUSK | 1.37528020 |
| 21 | DAPK2 | 1.33138994 |
| 22 | CSF1R | 1.32174975 |
| 23 | TAOK1 | 1.30024820 |
| 24 | TNK2 | 1.29937566 |
| 25 | IRAK3 | 1.29394918 |
| 26 | RET | 1.25480658 |
| 27 | RIPK1 | 1.25475421 |
| 28 | ERN1 | 1.17279228 |
| 29 | CAMKK1 | 1.15191373 |
| 30 | MAP3K11 | 1.14842895 |
| 31 | ARAF | 1.11557832 |
| 32 | PDK1 | 1.11490065 |
| 33 | MAP2K3 | 1.06752033 |
| 34 | ZAP70 | 1.06220201 |
| 35 | TAOK2 | 1.04922008 |
| 36 | SMG1 | 1.03820568 |
| 37 | TESK2 | 1.02324342 |
| 38 | SIK3 | 1.02003503 |
| 39 | MAP3K3 | 0.98515167 |
| 40 | BLK | 0.97213192 |
| 41 | MINK1 | 0.96287867 |
| 42 | PRKD1 | 0.94862203 |
| 43 | STK24 | 0.94616648 |
| 44 | DAPK3 | 0.93938012 |
| 45 | EPHA4 | 0.93011491 |
| 46 | CAMK2G | 0.92101232 |
| 47 | SYK | 0.92039108 |
| 48 | TEC | 0.91054956 |
| 49 | MAPK12 | 0.90548334 |
| 50 | MAP3K1 | 0.88162584 |
| 51 | NTRK3 | 0.85910709 |
| 52 | PRPF4B | 0.85246514 |
| 53 | FGFR4 | 0.82065832 |
| 54 | BMPR2 | 0.80527854 |
| 55 | MAP2K1 | 0.80369783 |
| 56 | MAP3K12 | 0.79850726 |
| 57 | RPS6KA2 | 0.79806210 |
| 58 | PRKG2 | 0.79168408 |
| 59 | CAMK2B | 0.78417817 |
| 60 | MAP2K2 | 0.77726191 |
| 61 | PIM2 | 0.77607263 |
| 62 | KSR2 | 0.77415690 |
| 63 | PRKCI | 0.76728705 |
| 64 | MARK2 | 0.75924730 |
| 65 | MAP3K2 | 0.73884509 |
| 66 | PIK3CA | 0.72418492 |
| 67 | EEF2K | 0.70708611 |
| 68 | ERBB2 | 0.70471462 |
| 69 | PAK1 | 0.70061682 |
| 70 | TAOK3 | 0.69404096 |
| 71 | HCK | 0.68508546 |
| 72 | SIK2 | 0.68406908 |
| 73 | DAPK1 | 0.67523135 |
| 74 | MST1R | 0.67086772 |
| 75 | CDC42BPA | 0.66432877 |
| 76 | RPS6KB2 | 0.65512877 |
| 77 | CAMK2D | 0.64522678 |
| 78 | EPHB1 | 0.64437786 |
| 79 | HIPK2 | 0.60810086 |
| 80 | EPHA3 | 0.60491042 |
| 81 | FGR | 0.58406497 |
| 82 | ICK | 0.56929104 |
| 83 | SGK3 | 0.52887330 |
| 84 | FER | 0.52314565 |
| 85 | LRRK2 | 0.51885320 |
| 86 | IRAK2 | 0.51739891 |
| 87 | NEK6 | 0.51681131 |
| 88 | MAP3K6 | 0.50043252 |
| 89 | MAP3K5 | 0.48889669 |
| 90 | MAP2K6 | 0.48695150 |
| 91 | PKN1 | 0.48497849 |
| 92 | PTK6 | 0.48130273 |
| 93 | PRKD2 | 0.47219637 |
| 94 | ROCK1 | 0.46438821 |
| 95 | DMPK | 0.43364992 |
| 96 | MATK | 0.42733627 |
| 97 | DYRK1B | 0.41113327 |
| 98 | CSK | 0.40973771 |
| 99 | ITK | 0.40052416 |
| 100 | IKBKB | 0.39695353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 3.09021810 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.94660771 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94304095 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.81933643 |
| 5 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.77913165 |
| 6 | Gap junction_Homo sapiens_hsa04540 | 1.65031578 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.63143186 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53466978 |
| 9 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.48808937 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40971933 |
| 11 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40347522 |
| 12 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33511732 |
| 13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27621364 |
| 14 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.27012754 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.24531743 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.22334989 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22234415 |
| 18 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21793652 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.19397491 |
| 20 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.18776619 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17883353 |
| 22 | Endocytosis_Homo sapiens_hsa04144 | 1.17792507 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16924864 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16376587 |
| 25 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.15282353 |
| 26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14192705 |
| 27 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.10533770 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09556131 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06062099 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04715186 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04483203 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04081856 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02701080 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02390608 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02091247 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00620940 |
| 37 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98607421 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 0.97817067 |
| 39 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.94224596 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92802827 |
| 41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92542046 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91728047 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91113427 |
| 44 | Morphine addiction_Homo sapiens_hsa05032 | 0.90800147 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90189958 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88688424 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88387512 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87035872 |
| 49 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86614251 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85347851 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85044876 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84868583 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84095043 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.83907386 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83630650 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83328765 |
| 57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82882533 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82692418 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82176019 |
| 60 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81887297 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80131735 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80009809 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79948346 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.79854359 |
| 65 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79177180 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79108839 |
| 67 | Alcoholism_Homo sapiens_hsa05034 | 0.77668098 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77364882 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77182336 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76791528 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.75008371 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72205787 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.71261039 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71183097 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.68672635 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67761019 |
| 77 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66701510 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64261399 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63808530 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.61465884 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60067112 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60043671 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59648024 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.59214526 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58667336 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58368098 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56929818 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56354220 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56320637 |
| 90 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54964396 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54828842 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54752756 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54455741 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.53198473 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52523500 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52507938 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52246923 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.52138788 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51538244 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51011506 |

